Inhibition of RIPK3 attenuated cardiac ischemia‒reperfusion injury [58] and sepsis [59] by reducing mitochondrial dysfunction, and inhibition of the RIPK1-RIPK3 pathway reduced tumor cell metastasis by decreasing vascular endothelial permeability [60]. The gene discussed is RIPK3; the disease is neoplasm.